Daihan Pharmaceutical Launches 'Liposome Albumin King' with Enhanced Bioavailability

Combining 100% Albumin Complex with Liposome Formulation Technology

Daihan Pharmaceutical announced on March 12, 2026, that it has expanded its high-content albumin brand lineup 'Albumin King' by launching 'Liposome Albumin King,' which increases bioavailability in the body.

This product utilizes Daihan Pharmaceutical's proprietary technology, applying the 'liposome formulation technology,' in which nutrients are encapsulated by phospholipids similar to human cell membranes. Liposome formulation technology is effective in delivering nutrients stably into the body, thereby enhancing absorption compared to conventional formulations.

The main ingredient of the product is a 100% albumin complex, which has undergone strict quality control. Each bottle of Liposome Albumin King contains 33,000 mg of high-content protein blend, designed to efficiently deliver nutrition. The product retains the liquid ampoule form, which had been highly preferred by existing consumers, to further enhance convenience of intake.

This content was produced with the assistance of AI translation services.